Venture-Backed Startups
124,685 companies with verified investor relationships.
Non-surgical, non-pharmacologic devices to induce weight loss
2 investors
0 investors
BaroPace is developing PressurePace, a closed-loop system that adjusts a cardiac pacemaker in response to real-time blood pressure measurements to treat drug-resistant hypertension and common forms of heart failure. The technology is based on the theory and clinical data of Dr. Michael Burnam linking declining heart rate to hypertensive disease and heart failure.
0 investors
0 investors
Barr Hill is a Vermont-based craft distillery that produces Landcrafted spirits inspired by the local landscape, offering cocktails, tastings, and tours at its Montpelier distillery. It also runs pollinator conservation initiatives such as Bee's Knees Week.
1 investor
Barracuda provides a cybersecurity platform (BarracudaONE) covering email, data, application, and network protection, along with a managed XDR service for threat detection and incident response. It serves businesses of all sizes worldwide.
4 investors
Barracuda XDR is an extended detection and response platform designed for managed service providers to offer centralized cybersecurity monitoring, threat detection, and incident response services. The platform aggregates security data across multiple environments and includes a global 24/7 security operations center with AI-powered analytics and automation capabilities.
1 investor
BarRaiser offers Interview as a Service, using a global pool of trained expert interviewers and an AI platform to conduct structured technical and other role-based interview rounds on behalf of hiring companies. It delivers recorded interviews, skill-wise scorecards, and hire/no-hire recommendations to help engineering and talent acquisition teams outsource their interviewing process.
1 investor
2 investors
Barrel Proof is a neighborhood whiskey and cocktail bar offering over 300 whiskeys along with spirits and bar food. It is located in Atlanta's Westside Provisions/West Midtown area.
0 investors
Barrel Proof is a whiskey and cocktail bar in Nashville's Germantown neighborhood, offering over 300 whiskeys from the US and abroad along with spirits across every category. It is the second location of the New Orleans bar, serving locals and visitors in a neighborhood bar setting.
0 investors
0 investors
0 investors
0 investors
Barrell Craft Spirits sources and blends whiskeys and other spirits from established producers, bottling cask-strength small-batch and single-barrel releases without chill filtration. Founded in 2013 and based in Louisville, Kentucky, its products are sold across 49 U.S. states, Puerto Rico, the UK, South Korea, Ukraine, and Australia.
0 investors
0 investors
Barrelmark (operating as The Bourbon Brokerage) provides brokerage and advisory services to spirits producers, helping them bring their products to market. Its team offers industry expertise in sales, marketing, and business development for spirit brands.
0 investors
BarrelRM is a contract beverage manufacturer offering turnkey production for spirits and ready-to-drink/ready-to-serve products, including private label development, compliance, bottling, and distribution. It serves beverage brand founders, retailers, and entrepreneurs looking to launch or scale spirits lines, and includes an R&D lab and a rapid maturation process.
1 investor
0 investors
BarrelWise makes the FS1, a device that lets cellar workers measure free SO₂ directly at wine barrels with results uploaded to a cloud database for winemakers and lab teams to analyze. The company serves wineries, aiming to replace lab-centric SO₂ sampling with a faster barrel-by-barrel process.
2 investors
Barrett Productions develops mobile apps with 3D graphics, including educational math games used by students across school districts, as well as physical products such as environmentally friendly tableware and finger-strengthening rehabilitation and sports devices like the SPORTSGRIP. Its rehabilitation products are distributed worldwide through Performance Health.
0 investors
0 investors
0 investors
Barricade Therapeutics is a clinical-stage oncology company developing BT-1501, an investigational once-daily oral small-molecule EBP inhibitor built on its TASIN platform to target genetic drivers of colorectal cancer. The therapy is aimed at patients with advanced and metastatic colorectal cancer and is advancing toward IND submission and first-in-human clinical trials.
1 investor